Irisin Mitigates Doxorubicin-Induced Cardiotoxicity by Reducing Oxidative Stress and Inflammation via Modulation of the PERK-eIF2α-ATF4 Pathway

Irisin Mitigates Doxorubicin-Induced Cardiotoxicity by Reducing Oxidative Stress and Inflammation via Modulation of the PERK-eIF2α-ATF4 Pathway

Zilong Zhang,* Xiaolin Yu,* Jie Li, Xin Shen, Wenbo Fu, Yongguo Liu, Xiangyu Dong, Zhao Wang Department of Cardiology, Cardiac and Pan - Vascular Medicine Center, People’s Hospital of Xinjiang Uygur Autonomous Region, Xinjiang, People’s Republic of China*These authors contrib...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhang Z, Yu X, Li J, Shen X, Fu W, Liu Y, Dong X, Wang Z
Format: Article
Language:English
Published: Dove Medical Press 2025-02-01
Series:Drug Design, Development and Therapy
Subjects:
irisin
doxorubicin
cardiac injury
perk-eif2α-atf4
Online Access:https://www.dovepress.com/irisin-mitigates-doxorubicin-induced-cardiotoxicity-by-reducing-oxidat-peer-reviewed-fulltext-article-DDDT
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.dovepress.com/irisin-mitigates-doxorubicin-induced-cardiotoxicity-by-reducing-oxidat-peer-reviewed-fulltext-article-DDDT

Similar Items